PROCESS FOR PREPARING A BIPHENYL-2-YLCARBAMIC ACID
    8.
    发明申请
    PROCESS FOR PREPARING A BIPHENYL-2-YLCARBAMIC ACID 有权
    制备二苯基-2-亚油酸的方法

    公开(公告)号:US20140121378A1

    公开(公告)日:2014-05-01

    申请号:US14090211

    申请日:2013-11-26

    IPC分类号: C07D401/12

    CPC分类号: C07D401/12 C07D211/46

    摘要: The invention provides a process of preparing an intermediate useful in the synthesis of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl ester, and a process of preparing a crystalline freebase of the ester.

    摘要翻译: 本发明提供了制备可合成联苯-2-基氨基甲酸1-(2 - {[4-(4-氨基甲酰基哌啶-1-基甲基)苯甲酰基]甲基氨基}乙基)哌啶-4-基酯 ,以及制备酯的结晶游离碱的方法。

    CRYSTALLINE FORMS OF AN 8-AZABICYCLO[3.2.1]OCTANE COMPOUND
    9.
    发明申请
    CRYSTALLINE FORMS OF AN 8-AZABICYCLO[3.2.1]OCTANE COMPOUND 有权
    8-亚氨基二环[3.2.1]化合物的晶体形式

    公开(公告)号:US20110184008A1

    公开(公告)日:2011-07-28

    申请号:US13081162

    申请日:2011-04-06

    摘要: The invention provides a crystalline sulfate salt of 3-endo-(8-{2-[cyclohexylmethyl-((S)-2,3-dihydroxy-propionyl)amino]ethyl}-8-aza-bicyclo[3.2.1]oct-3-yl)benzamide or a solvate thereof. The invention also provides pharmaceutical compositions comprising such crystalline salt forms, methods of using such crystalline salt forms to treat diseases associated with mu opioid receptor activity, and processes useful for preparing such crystalline salt forms.

    摘要翻译: 本发明提供3-内 - (8- {2- [环己基甲基 - ((S)-2,3-二羟基 - 丙酰基)氨基]乙基} -8-氮杂 - 双环[3.2.1]辛烷的结晶硫酸盐 -3-基)苯甲酰胺或其溶剂合物。 本发明还提供包含这种结晶盐形式的药物组合物,使用这种结晶盐形式治疗与阿片样物质受体活性相关的疾病的方法,以及可用于制备此类结晶盐形式的方法。